Versant Capital Management, Inc Pacira Bio Sciences, Inc. Transaction History

Versant Capital Management, Inc

$578 Million
Q1 2025

A detailed history of Versant Capital Management, Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,052 shares of PCRX stock, worth $26,773. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,052

Previous 1,052 -0.0%

Holding current value

$26,773

Previous $19,000 36.84%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 02, 2025	BUY	$15.3 - $20.33 $3,151 - $4,187	206 Added 24.35%	1,052 $19,000
Q3 2024 Oct 07, 2024	BUY	$11.7 - $28.46 $9,711 - $23,621	830 Added 5187.5%	846 $12,000
Q4 2023 Jan 08, 2024	SELL	$26.32 - $34.31 $315 - $411	-12 Reduced 42.86%	16 $0
Q3 2023 Oct 11, 2023	SELL	$30.68 - $40.09 $552 - $721	-18 Reduced 39.13%	28 $0
Q2 2023 Jul 10, 2023	BUY	$36.12 - $47.5 $650 - $855	18 Added 64.29%	46 $1,000
Q4 2022 Jan 25, 2023	SELL	$38.19 - $57.45 $2,138 - $3,217	-56 Reduced 66.67%	28 $0
Q3 2022 Dec 30, 2022	BUY	$51.24 - $58.89 $3,996 - $4,593	78 Added 1300.0%	84 $4,000
Q2 2022 Aug 02, 2022	SELL	$51.49 - $81.64 $1,802 - $2,857	-35 Reduced 85.37%	6 $0
Q1 2022 Apr 29, 2022	BUY	$60.03 - $76.49 $2,101 - $2,677	35 Added 583.33%	41 $3,000
Q2 2021 Jul 22, 2021	SELL	$59.18 - $69.99 $6,687 - $7,908	-113 Reduced 94.96%	6 $0
Q1 2021 Apr 27, 2021	SELL	$59.31 - $78.82 $1,957 - $2,601	-33 Reduced 21.71%	119 $8,000
Q2 2020 Jul 16, 2020	BUY	$30.8 - $52.47 $2,587 - $4,407	84 Added 123.53%	152 $7,000
Q1 2020 Apr 17, 2020	SELL	$28.4 - $50.7 $2,811 - $5,019	-99 Reduced 59.28%	68 $2,000
Q4 2019 Jan 28, 2020	BUY	$36.31 - $46.83 $6,063 - $7,820	167 New	167 $7,000
Q3 2017 Apr 23, 2018	SELL	$35.7 - $39.5 $249 - $276	-7 Closed	0 $0
Q1 2017 Apr 23, 2018	BUY	N/A	7	7 $0

Others Institutions Holding PCRX

# of Institutions

258

Shares Held

49.4M

Call Options Held

1.03M

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.17B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account

Versant Capital Management, Inc Pacira Bio Sciences, Inc. Transaction History